{
    "title": "Semi-activated Vitamin D given weekly (used by Spanish COVID-19 trial) \u2013 US patent application",
    "slug": "semi-activated-vitamin-d-given-weekly-used-by-spanish-covid-19-trial-us-patent-application",
    "aliases": [
        "/Semi-activated+Vitamin+D+given+weekly+used+by+Spanish+COVID-19+trial+\u2013+US+patent+application+Sept+2020",
        "/11973"
    ],
    "tiki_page_id": 11973,
    "date": "2020-09-23",
    "categories": [
        "Patent",
        "Calcidiol"
    ],
    "tags": [
        "Calcidiol",
        "Patent",
        "blood levels",
        "vitamin d"
    ]
}


#### Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration

United States Patent Application 20200281947 Kind Code:A1

Inventors: Deluca, Hector F. (Deerfield, WI, US). Plum, Lori A. (Arena, WI, US), Clagett-dame, Margaret (Deerfield, WI, US)

An oral dosage form comprising a single dose of 25-hydroxy-vitamin D3 sufficient to elevate the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml for at least 7 days and a pharmaceutically suitable oral carrier system, wherein subsequent single doses at least every 7 days are sufficient to sustain the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml at steady-state pharmacokinetics is disclosed. A method of elevating and sustaining the blood level concentration of 25-hydroxy-vitamin D3 in a human in need thereof comprising 

* orally administering or 

* parenterally administering by injection or infusion, 

at least once every 7 days, a single dose of 25-hydroxy-vitamin D3 sufficient to elevate the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml for at least 7 days, wherein the single doses orally administered at least every 7 days are sufficient to sustain the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml at steady-state pharmacokinetics is disclosed. The human in need thereof may be a human deficient in vitamin D having a serum level concentration of 25-hydroxy-vitamin D3 less than 30 ng/ml.

[Patent Text](https://www.freepatentsonline.com/y2020/0281947.html)

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/patent-application-weekly.pdf">Download the Patent PDF image from VitaminDWiki</a>**